– Ascend Capital Partners (“Ascend”), a healthcare-focused private equity firm, announced the final close of Ascend Capital Partners Fund II, L.P. and Parallel
– Vehicles (“Ascend Fund II”) with $791 million in total commitments, exceeding its initial $700 million target.
– Ascend Fund II received strong support from existing and new limited partners across public and private pension funds, foundations, endowments, consultants, family offices, and funds of funds, reflecting alignment with
– Ascend’s mission, investment strategy, and operating approach.
– Ascend’s inaugural fund closed at its $570 million hard cap in December 2021 and is now fully deployed across eight investments.
– Ascend Fund II will invest in physician and provider services, value-based care enablement companies, and healthcare IT, leveraging Ascend’s operational expertise to strengthen healthcare delivery operations.
– The firm continues to partner with physicians, clinical leaders, and management teams to build scaled platforms that enhance clinical quality, operational performance, and sustainable growth.
– In Seon Hwang, Managing Partner at Ascend, emphasized gratitude for limited partners’ support and highlighted the firm’s focus on improving patient outcomes while generating durable, long-term value.
– Dr. Richard Park, MD, Managing Partner at Ascend, noted the firm’s commitment to strengthening healthcare quality, expanding access, and improving patient outcomes through operational expertise and in-house resources.
– Ascend Fund II is actively deploying capital, with investments already made in Seoul Medical Group and Unison Therapy Services.
